SCD and cancer: In summary, the excess MUFA biosynthesis produced by high SCD1 is not just a byproduct of metabolic transformation but an influential factor in the dual control of global lipid biosynthesis and survival signaling cascades which, as it is described below, will ultimately modulate central biological mechanisms in cancer cells.